Zobrazeno 1 - 10
of 74
pro vyhledávání: '"R, Golbey"'
Publikováno v:
Cancer. 50(6)
Seventeen patients with malignant ovarian germ cell tumors were treated with vinblastine, actinomycin D, bleomycin and cisplatin containing combinations. Many of these patients were heavily pretreated. Thirteen patients had objectively measurable dis
Publikováno v:
Cancer treatment reports. 66(6)
Twenty-four patients with epidermoid carcinoma of the esophagus have been treated, in a phase II trial, with methyl-GAG using a weekly schedule. Eighteen patients had received prior chemotherapy with cisplatin-containing combinations. Of 23 evaluable
Publikováno v:
Seminars in oncology. 6(1)
Publikováno v:
Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer. (60)
1. Seminoma may occasionally be rapidly growing, aggressive, radioresistant, and chemotherapy-resistant tumor. 2. Alkylating agents have had the greatest number of trials and have produced the best response rates in the management of seminoma, but a
Publikováno v:
Cancer. 43(1)
Sixty-seven patients with measurable colorectal carcinoma were randomized to receive two different schedules of Methyl CCNU, 5-FU and Vincristine (MOF). The treatment schedule consisted of Methyl CCNU 150 mg/m2 po q 70 days, 5-FU 300 mg/m2 iv for 5 c
SummaryA total of 161 patients with non-small cell lung cancer have been treated with either cisplatin and vindesine or with cisplatin, vindesine, Cytoxan and adriamycin. All patients have measurable
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8a08ccda7842f57519c56ef920c2e81b
https://doi.org/10.1159/000428668
https://doi.org/10.1159/000428668
Autor:
H I, Scher, B, Shank, R, Chapman, N, Geller, C, Pinsky, R, Gralla, D, Kelsen, G, Bosl, R, Golbey, G, Petroni
Publikováno v:
Cancer research. 48(6)
A randomized trial of thymosin fraction V (60 mg/m2 s.c. twice weekly) given during induction chemotherapy and radiation therapy was performed in 91 patients with small cell carcinoma of the lung. Induction chemotherapy consisted of four cycles of an
Publikováno v:
Cancer clinical trials. 4(4)
Fifty-two patients with metastatic or recurrent non-small-cell lung cancer (NSCLC) were treated, during a phase II trial, with methylglyoxal-bis-(guanylhydrazone) (MGBG). Of the 44 patients who had adequate trials, 4 had partial responses (PR), for a
Publikováno v:
Cancer treatment reports. 66(2)
Seventy-four patients with non-small cell lung cancer were treated in a prospective, randomized trial either with a four-drug combination of cisplatin, doxorubicin, cyclophosphamide, and vindesine (PACE) or with a three-drug combination of cisplatin,
Publikováno v:
Cancer treatment reports. 63(11-12)
Vindesine, a new vinca alkaloid, has shown therapeutic activity in several human malignancies. A phase II study in 26 patients with squamous cell carcinoma of the esophagus was performed. Sixty percent of these patients had received prior chemotherap